Literature DB >> 27043022

Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe.

Resat Ozaras1, Mustafa Sunbul2, Mehmet Parlak3, Hurrem Bodur4, Hakan Leblebicioglu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27043022     DOI： 10.1002/hep.28592

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

Review 1.  Impact of etiological treatment on prognosis.

Authors:  Chien-Wei Su; Ying-Ying Yang; Han-Chieh Lin
Journal:  Hepatol Int       Date:  2017-07-12       Impact factor: 6.047

2.  No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

Authors:  Mark S Sulkowski; Wan-Long Chuang; Jia-Horng Kao; Jenny C Yang; Bing Gao; Diana M Brainard; Kwang-Hyub Han; Edward Gane
Journal:  Clin Infect Dis       Date:  2016-08-02       Impact factor: 9.079
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.